Results 261 to 270 of about 1,070,434 (330)

Mortality Fractions Attributable to Smoking and Smokeless and Mixed Tobacco Use Among Men and Women Across India, 1998-2021. [PDF]

Nicotine Tob Res
Shaikh R, Vogt T, Saikia N, Pednekar MS, Gupta PC, Janssen F.   +5 more
europepmc   +1 more source

Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York

ESC Heart Failure, Volume 12, Issue 2, Page 819-831, April 2025.
Abstract Background Seasonal variations have been observed in heart failure (HF) hospitalization. Numerous explanatory mechanisms have been proposed, but no prior studies have examined potential contributors directly. Our objective was to identify specific factors that could contribute to seasonal variability using a large longitudinal dataset of HF ...
Prerna Gupta, Ellen Brinza, Prateeti Khazanie, Pamela N. Peterson, P Michael Ho, David P. Kao   +5 more
wiley   +1 more source

Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy

European Journal of Heart Failure, EarlyView.
Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy. CVF, left ventricular collagen volume fraction; DCM, dilated cardiomyopathy; EMB, endomyocardial biopsy; LV, left ventricular. Aims The need to perform endomyocardial biopsy (EMB) in patients with non‐ischaemic dilated cardiomyopathies (DCM) is debated ...
Elham Kayvanpour, Farbod Sedaghat‐Hamedani, Daniel Tian Li, Ebe Amr, Ali Amr, Bernd Lahrmann, Alan Lai, Christoph Reich, Chenyang Wang, Esther Herpel, Derliz Mereles, Lutz Frankenstein, Niels Grabe, Hugo A. Katus, Norbert Frey, Benjamin Meder   +15 more
wiley   +1 more source

Social determinants of alcohol and tobacco use among Hispanic adolescents: a scoping review. [PDF]

Front Psychiatry
Silmi KP, Castillo V, Segura N, Cervantes NC, Perez Y, Valenzuela A, Pugh EA, Unger JB, Gonzalez MR.   +8 more
europepmc   +1 more source

Self‐Discontinuity as a Barrier to Identity and Behaviour Change: Evidence From Smoking Cessation

European Journal of Social Psychology, EarlyView.
ABSTRACT Extensive research has shown that resistance to behaviour change is often driven by the management of self‐related threats, traditionally conceptualized as threats to self‐esteem. The present research offers a novel perspective by examining behaviour change as a threat to self‐continuity (i.e., the perceived stability of one's self‐image over ...
Jérôme Blondé, Juan Manuel Falomir‐Pichastor   +1 more
wiley   +1 more source

A comparison of classifications for geographic location and their associations with tobacco use among US adults. [PDF]

J Rural Health
Ozga JE, Milstred A, Blank MD, Rayens MK, Keller-Hamilton B, Roberts ME, Himelhoch S, Stanton CA.   +7 more
europepmc   +1 more source

Sustainability in Analytical Chemistry Illustrated by Pharmaceutical Nitrosamine Testing

ELECTROPHORESIS, EarlyView.
ABSTRACT Following the valsartan scandal in 2018, the testing of drug substances and drug products for N‐nitrosamines has become a critical and mandatory quality control measure. The European Pharmacopoeia chapter 2.5.42 currently describes three analytical methods for this purpose: HPLC–MS/MS, GC–MS, and GC–MS/MS.
Felix Bredendiek, Sebastian Schmidtsdorff, Maria Kristina Parr   +2 more
wiley   +1 more source

Text Message (SMS) Microlearning for Tobacco Use Disorder: Pre-Post Pilot Study of Clinician Confidence.

JMIR Med Educ
Dhanani Z, Dronamraju V, Garfield J.
europepmc   +1 more source

Unveiling the socio contextual triggers of smokeless tobacco use among blue collar workers: implications for workplace health and policy. [PDF]

Sci Rep
Bandyopadhyay A, Pahari S, Pahari MP, Keswani S.   +3 more
europepmc   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source